Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...
Newsner on MSN
Bladder cancer survivors speak out on most common first symptom they all had before diagnosis
Bladder cancer can develop without causing someone to feel noticeably sick, which is why recognizing potential warning signs ...
Mens Fitness on MSN
New FDA approval aims to help patients avoid bladder removal surgery
The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...
What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...
A retrospective study of 126 bladder cancer patients suggests that ERAS-based perioperative nursing care is associated with ...
Bladder cancer surgery is a major procedure, so if you find that your recovery process is taking some time, it’s completely ...
FDA expands Anktiva approval for BCG-unresponsive bladder cancer. Learn about the 62% trial response, eligible patients, ...
The approval adds patients with high-grade papillary-only tumors, based on trial data showing a 62% complete response rate in ...
Nogapendekin alfa inbakicept-pmln (Anktiva; ImmunityBio Inc) given with Bacillus Calmette-Guérin (BCG) is now the first ...
Not everyone with kidney cancer will experience all of these symptoms. Only 10 percent to 15 percent of patients have the “ ...
The FDA extended Anktiva to high-grade papillary-only bladder cancer that no longer responds to BCG. Its reasoning rests on a ...
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results